These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


458 related items for PubMed ID: 17331188

  • 1. RCAN1-1L is overexpressed in neurons of Alzheimer's disease patients.
    Harris CD, Ermak G, Davies KJ.
    FEBS J; 2007 Apr; 274(7):1715-24. PubMed ID: 17331188
    [Abstract] [Full Text] [Related]

  • 2. Expression of tau mRNA and soluble tau isoforms in affected and non-affected brain areas in Alzheimer's disease.
    Boutajangout A, Boom A, Leroy K, Brion JP.
    FEBS Lett; 2004 Oct 08; 576(1-2):183-9. PubMed ID: 15474035
    [Abstract] [Full Text] [Related]

  • 3. DSCR1/RCAN1 regulates vesicle exocytosis and fusion pore kinetics: implications for Down syndrome and Alzheimer's disease.
    Keating DJ, Dubach D, Zanin MP, Yu Y, Martin K, Zhao YF, Chen C, Porta S, Arbonés ML, Mittaz L, Pritchard MA.
    Hum Mol Genet; 2008 Apr 01; 17(7):1020-30. PubMed ID: 18180251
    [Abstract] [Full Text] [Related]

  • 4. Differential expression of members of the RCAN family of calcineurin regulators suggests selective functions for these proteins in the brain.
    Porta S, Martí E, de la Luna S, Arbonés ML.
    Eur J Neurosci; 2007 Sep 01; 26(5):1213-26. PubMed ID: 17767500
    [Abstract] [Full Text] [Related]

  • 5. Apolipoprotein C-I expression in the brain in Alzheimer's disease.
    Petit-Turcotte C, Stohl SM, Beffert U, Cohn JS, Aumont N, Tremblay M, Dea D, Yang L, Poirier J, Shachter NS.
    Neurobiol Dis; 2001 Dec 01; 8(6):953-63. PubMed ID: 11741391
    [Abstract] [Full Text] [Related]

  • 6. The alternative splicing of tau exon 10 and its regulatory proteins CLK2 and TRA2-BETA1 changes in sporadic Alzheimer's disease.
    Glatz DC, Rujescu D, Tang Y, Berendt FJ, Hartmann AM, Faltraco F, Rosenberg C, Hulette C, Jellinger K, Hampel H, Riederer P, Möller HJ, Andreadis A, Henkel K, Stamm S.
    J Neurochem; 2006 Feb 01; 96(3):635-44. PubMed ID: 16371011
    [Abstract] [Full Text] [Related]

  • 7. Regulation of RCAN1 translation and its role in oxidative stress-induced apoptosis.
    Wu Y, Song W.
    FASEB J; 2013 Jan 01; 27(1):208-21. PubMed ID: 23038757
    [Abstract] [Full Text] [Related]

  • 8. Brain expression of the calcineurin inhibitor RCAN1 (Adapt78).
    Mitchell AN, Jayakumar L, Koleilat I, Qian J, Sheehan C, Bhoiwala D, Hushmendy SF, Heuring JM, Crawford DR.
    Arch Biochem Biophys; 2007 Nov 15; 467(2):185-92. PubMed ID: 17910944
    [Abstract] [Full Text] [Related]

  • 9. Density of Sgt1-immunopositive neurons is decreased in the cerebral cortex of Alzheimer's disease brain.
    Spiechowicz M, Bernstein HG, Dobrowolny H, Leśniak W, Mawrin C, Bogerts B, Kuźnicki J, Filipek A.
    Neurochem Int; 2006 Oct 15; 49(5):487-93. PubMed ID: 16698122
    [Abstract] [Full Text] [Related]

  • 10. Reactivation of HSV-1 in the brain of patients with familial Alzheimer's disease.
    Mori I, Kimura Y, Naiki H, Matsubara R, Takeuchi T, Yokochi T, Nishiyama Y.
    J Med Virol; 2004 Aug 15; 73(4):605-11. PubMed ID: 15221907
    [Abstract] [Full Text] [Related]

  • 11. Two polymorphisms of RCAN1 gene associated with Alzheimer's disease in the Chinese Han population.
    Lin KG, Tang M, Guo YB, Han HY, Lin YH.
    East Asian Arch Psychiatry; 2011 Jun 15; 21(2):79-84. PubMed ID: 21838211
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Differential expression of N-methyl-D-aspartate receptor NR2 isoforms in Alzheimer's disease.
    Hynd MR, Scott HL, Dodd PR.
    J Neurochem; 2004 Aug 15; 90(4):913-9. PubMed ID: 15287897
    [Abstract] [Full Text] [Related]

  • 14. Single molecule profiling of tau gene expression in Alzheimer's disease.
    Conrad C, Zhu J, Conrad C, Schoenfeld D, Fang Z, Ingelsson M, Stamm S, Church G, Hyman BT.
    J Neurochem; 2007 Nov 15; 103(3):1228-36. PubMed ID: 17727636
    [Abstract] [Full Text] [Related]

  • 15. Ectopic expression of phospho-Smad2 in Alzheimer's disease: uncoupling of the transforming growth factor-beta pathway?
    Lee HG, Ueda M, Zhu X, Perry G, Smith MA.
    J Neurosci Res; 2006 Dec 15; 84(8):1856-61. PubMed ID: 16998902
    [Abstract] [Full Text] [Related]

  • 16. Lysosome-associated membrane protein 1 (LAMP-1) in Alzheimer's disease.
    Barrachina M, Maes T, Buesa C, Ferrer I.
    Neuropathol Appl Neurobiol; 2006 Oct 15; 32(5):505-16. PubMed ID: 16972884
    [Abstract] [Full Text] [Related]

  • 17. Over-expression of c-fos mRNA in the hippocampal neurons in Alzheimer's disease.
    Lu W, Mi R, Tang H, Liu S, Fan M, Wang L.
    Chin Med J (Engl); 1998 Jan 15; 111(1):35-7. PubMed ID: 10322650
    [Abstract] [Full Text] [Related]

  • 18. RCAN1-4 knockdown attenuates cell growth through the inhibition of Ras signaling.
    Lee HJ, Kim YS, Sato Y, Cho YJ.
    FEBS Lett; 2009 Aug 06; 583(15):2557-64. PubMed ID: 19619541
    [Abstract] [Full Text] [Related]

  • 19. Neuronal expression of GFAP in patients with Alzheimer pathology and identification of novel GFAP splice forms.
    Hol EM, Roelofs RF, Moraal E, Sonnemans MA, Sluijs JA, Proper EA, de Graan PN, Fischer DF, van Leeuwen FW.
    Mol Psychiatry; 2003 Sep 06; 8(9):786-96. PubMed ID: 12931206
    [Abstract] [Full Text] [Related]

  • 20. Human neurons express type I GnRH receptor and respond to GnRH I by increasing luteinizing hormone expression.
    Wilson AC, Salamat MS, Haasl RJ, Roche KM, Karande A, Meethal SV, Terasawa E, Bowen RL, Atwood CS.
    J Endocrinol; 2006 Dec 06; 191(3):651-63. PubMed ID: 17170222
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 23.